Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/4560
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNargiza Parpiyeva1 , Talgat Galiulin2 , Irina Liverko3 , Elnora Abduganieva4 , Abduvahid Sadikov5-
dc.date.accessioned2026-06-24T06:08:46Z-
dc.date.available2026-06-24T06:08:46Z-
dc.date.issued2020-
dc.identifier.issn2515-8260-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/4560-
dc.description.abstractA total of 2105 patients with pulmonary tuberculosis were examined, of which 19.5% of patients were found to have concomitant pathology. It was found that in patients with concomitant pathologies, tuberculosis is severe, with severe symptoms of intoxication and respiratory manifestations. Isolation of MBT and the presence of drug resistance were higher in the group of patients with concomitant pathology. The presence of concomitant pathology adversely affects the clinical course of pulmonary tuberculosis.en_US
dc.language.isoen_USen_US
dc.publisherEuropean Journal of Molecular & Clinical Medicine Volume 07, Issue 03,en_US
dc.subjectpulmonary, tuberculosis, MBTen_US
dc.titleInfluence Of Concurrent Pathology On The Clinical Course Of Pulmonary Tuberculosisen_US
dc.typeArticleen_US
Appears in Collections:

Files in This Item:
File Description SizeFormat 
6. EJMCM_Volume 7_Issue 3_Pages 3920-3923.pdf221.18 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.